KIRAN MEHTA
Sleep Medicine (Internal Medicine) Physician in HOLLYWOOD, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KIRAN MEHTA reported a CMS MIPS final score of 77.5073/100 — below the 83.1 national average — and filed 935 Medicare Part D claims in 2023.
- 77.5073/100
- MIPS score · -6 vs avg
- 935
- Part D claims, 2023
- 33%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KIRAN MEHTA's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
78 24th percentile higher than 24% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
KIRAN MEHTA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about KIRAN MEHTA?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Maryland
How Sleep Medicine (Internal Medicine) Physician compares to other specialties among Maryland providers
Sleep Medicine (Internal Medicine) Physician share within Maryland
Sleep Medicine (Internal Medicine) Physician is one of the more visible NUCC categories in Maryland
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KIRAN MEHTA's 2023 MIPS final score plotted against the Sleep Medicine (Internal Medicine) Physician national average
- MIPS Final Score
- 77.5073/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Sleep Medicine (Internal Medicine) Physician) — 77.5073/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Sleep Medicine (Internal Medicine) Physician US NPIs
77.5073/100 MIPS final score — 5.6 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Sleep Medicine (Internal Medicine) Physician. Quality dim: 53.3871. Cost dim: 74.9705.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KIRAN MEHTA appears in the CMS NPPES registry as a Sleep Medicine (Internal Medicine) Physician provider at 24035 THREE NOTCH RD, HOLLYWOOD, MD, 20636, with a listed phone of (301) 373-7900. NPI 1275552853 was issued on 07/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MEHTA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 935 prescription claims written by this provider, covering 142 Medicare beneficiaries and totaling roughly $439K in drug spend, split 67% brand-name and 33% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 77.5073/100 for the 2023 performance year (Quality 53.3871, Cost 74.9705), compared with the national average of 83.1.
Sleep Medicine (Internal Medicine) Physician is a narrow specialty nationwide, with 857 enrolled providers across 52 states and an average of 1,310 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1275552853 |
|---|---|
| Specialty | Sleep Medicine (Internal Medicine) Physician |
| Gender | Male |
| NPI Issued | 07/18/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KIRAN MEHTA's current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where KIRAN MEHTA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Brand-heavy
67% brand-name claims vs 33% generic, on 935 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,724
- Total Day Supply
- 50,121
- Brand vs Generic
- 67% brand / 33% generic
- Brand Drug Cost
- $419K
- Generic Drug Cost
- $20K
- Antibiotic Claims
- 29
Patient Demographics
- Average Patient Age
- 73.2 years
- Avg HCC Risk Score
- 1.56
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 18, 65-74: 63, 75-84: 45, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What KIRAN MEHTA prescribes most
Top Medicare Part D drugs by claim count, 2023
- Albuterol Sulfate …
Albuterol Sulfate Hfa
249 claims
- Trelegy Ellipta 92
Trelegy Ellipta
92 claims
- Montelukast Sodium 62
Montelukast Sodium
62 claims
- Anoro Ellipta 56
Anoro Ellipta
56 claims
- Symbicort 54
Symbicort
54 claims
- Stiolto Respimat 50
Stiolto Respimat
50 claims
- Spiriva Respimat 37
Spiriva Respimat
37 claims
- Ventolin Hfa 36
Ventolin Hfa
36 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 249 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 92 |
| Montelukast Sodium | 62 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 56 |
| Symbicort Budesonide/Formoterol Fumarate | 54 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 50 |
| Spiriva Respimat Tiotropium Bromide | 37 |
| Ventolin Hfa Albuterol Sulfate | 36 |
| Breo Ellipta Fluticasone/Vilanterol | 30 |
| Prednisone | 22 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Sleep Medicine (Internal Medicine) Physician Overview
How KIRAN MEHTA fits within the Sleep Medicine (Internal Medicine) Physician landscape nationally.
KIRAN MEHTA's 935 claims are below the specialty average of 1,310.
Nearby Sleep Medicine (Internal Medicine) Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as MEHTA.
Compare Sleep Medicine (Internal Medicine) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maryland
Frequently Asked Questions
What is KIRAN MEHTA's specialty? ▼
How much does KIRAN MEHTA prescribe under Medicare Part D? ▼
What is KIRAN MEHTA's Medicare quality score? ▼
Where is KIRAN MEHTA located? ▼
What is KIRAN MEHTA's NPI number? ▼
Does KIRAN MEHTA prescribe more brand-name or generic drugs? ▼
How many Sleep Medicine (Internal Medicine) Physician providers are there in the US? ▼
What drugs does KIRAN MEHTA prescribe most often? ▼
Does KIRAN MEHTA accept Medicare? ▼
How can I verify KIRAN MEHTA's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology